4-Ethoxyimino-N′-methoxypyrrolidin-1-ium-3-carboximidamidium dichloride

The title compound, C8H18N4O2 2+·2Cl−, contains two oxime groups. The methyl oxime group has a Z configuration, and the ethyl oxime group is disordered, with both Z and E configurations in occupancies of 0.840 (8) and 0.160 (8), respectively. In the crystal structure, there are a number of N—H⋯Cl hydrogen bonds.

[1]  Juxian Wang,et al.  tert-Butyl 4-carbamoyl-3-methoxyimino-4-methylpiperidine-1-carboxylate , 2008, Acta Crystallographica Section E.

[2]  S. H. Yoon,et al.  Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine. , 2004, Bioorganic & medicinal chemistry letters.

[3]  N. Osheroff,et al.  Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. , 2001, Current pharmaceutical design.

[4]  G. Tillotson,et al.  Therapeutic advances of new fluoroquinolones. , 1998, Expert opinion on investigational drugs.

[5]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[6]  S. R. Pathak,et al.  Organic carbamates in drug development. Part II: antimicrobial agents - recent reports , 2005 .